New case of mpox variant clade Ib detected in England

January 20, 2025
The UK Health Security Agency (UKHSA) has confirmed a sixth case of the mpox variant Clade Ib in England since October 2024. The latest case, identified in East Sussex, involves a patient who recently returned from Uganda, where community transmission of the variant is ongoing. Notably, this case has no links to the previous five. The Clade Ib variant, declared a global health emergency by the World Health Organization in August 2024, spreads more easily between people. While the UKHSA maintains that the risk to the general population remains low, the agency continues efforts to monitor and control potential transmission.
The UK Health Security Agency (UKHSA) announced another case of the mpox variant Clade Ib in England, marking the sixth confirmed instance since October 2024. The new case, detected in East Sussex, involves a patient who had recently traveled to Uganda, a region currently experiencing community transmission of the variant. Unlike the previous five cases, this case is unconnected to earlier incidents, highlighting the potential for isolated introductions linked to international travel.
First identified in Central Africa, Clade Ib mpox has been associated with increased human-to-human transmissibility, prompting the World Health Organization to declare it a global health emergency in August 2024. The variant causes symptoms such as fever, headaches, pus-filled lesions, and fatigue, though the UKHSA has reassured the public that the overall risk to the UK population remains low.
The five earlier cases in England included a cluster of household contacts stemming from an initial case in London, with another unrelated case in Leeds. The detection of this sixth, unlinked case underscores the need for robust monitoring and containment measures, particularly in light of increased international travel.
The UKHSA continues to implement stringent surveillance and rapid-response protocols, including monitoring returning travelers from affected regions and conducting contact tracing to prevent further spread. This proactive approach demonstrates the importance of global and national collaboration in addressing the challenges posed by emerging infectious diseases.
As Clade Ib mpox continues to circulate, particularly in Uganda and neighboring regions, the UK’s vigilance is a critical component of a broader international effort to contain outbreaks, minimize public health risks, and ensure readiness for future health emergencies.